Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Biotech
Pharma
Biotechnology
Merck and Co
Moderna
Amgen
Illumina
Celltrion
AbbVie
Gilead Sciences
GM Food
Genentech
Biogen
BioNTech
Novartis
Topics

Advertisement

Advertisement

Biotech

Share

Top Latest Popular

argenx agrees Unnatural takeover deal worth up to $1.15bn pharmaphorum 10h

pharmaphorum 10h

Dundee biotech PhaSER wins $2.7M Gates grant for infectious disease drugs The Next Web 13h

The Next Web 13h

Vir Biotechnology announces expanded Phase 2 SOLSTICE data for elebsiran and tobevibart in chronic Hepatitis Delta, showing deep and sustained viral suppression, and exploratory finite treatment data Business Wire (Press Release) 1d

Business Wire (Press Release) 1d

Advertisement

Vir Biotechnology announces primary endpoint met in pivotal Phase 3 ECLIPSE 1 trial for elebsiran and tobevibart in chronic Hepatitis Delta Business Wire (Press Release) 1d

Business Wire (Press Release) 1d

Advertisement

Cidebsirna normalizes liver fat and improves liver injury markers in masld patients, as highlighted at AASLD Regeneron Pharmaceuticals (Press Release) 1d

Regeneron Pharmaceuticals (Press Release) 1d

Why the latest heart drug failures should make us all more skeptical of AI hype STAT 2d

STAT 2d

Advertisement

Advertisement

Latest

In the last 15 minutes

Argenx adds peptide discovery engine with Unnatural Products M&A BioWorld 22:03

In the last half hour

Vir’s combo approach nails phase III endpoints in hepatitis D trial BioWorld 21:59

The big Piktor: Street keeps Faeth in endometrial post-phase II BioWorld 21:59

Avenzo Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in London Business Wire (Press Release) 21:56

CMS’ Medicare negotiations transition from guidance to rule BioWorld 21:49

US FDA warns of GLP-1 risk, weighs AAV malignancy risk BioWorld 21:49

In the last hour

Entropy's IV psilocybin moves toward precision psychiatry BioWorld 21:37

Srtd raises €31.5M seed round for disease-specific mRNAs BioWorld 21:18

In the last 2 hours

New Data At AHA 2026 Demonstrates The Value Of Treatment With Repatha® Earlier In The Cardiovascular Risk Continuum PR Newswire (Press Release) 21:02

Vir Biotechnology (VIR) Posts Positive Phase 3 HDV Data With Durable Follow Through Simply Wall St 20:37

Advertisement

Advertisement

Advertisement

Advertisement

About our Biotech news

Latest Biotech news, covering the latest bioinformatics, bioengineering and more from the Biotechnology industry.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna